Skip to main content
Top

2014 | OriginalPaper | Hoofdstuk

23. Maagcarcinoom

Auteur : Peter Siersema

Gepubliceerd in: Ontwikkelingen in de oncologie

Uitgeverij: Bohn Stafleu van Loghum

share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Inleiding

In 2005 kreeg ruim 3% van alle Nederlandse mannelijke kankerpatiënten een maagcarcinoom.1 Voor vrouwen lag dat percentage op ongeveer 2%. Het maagcarcinoom was vele jaren de meest voorkomende vorm van kanker in Nederland, maar de kans hierop neemt al een aantal decennia af (figuur 23.1) en daarmee ook de kans om te overlijden aan maagcarcinoom (figuur 23.2). Een veel hogere incidentie van het maagcarcinoom wordt gevonden in noordoost Azië, oost Europa en oostelijk Zuid-Amerika.
Literatuur
2.
go back to reference Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965;64:31–49.PubMed Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965;64:31–49.PubMed
3.
go back to reference Correa P. Human gastric carcinogenesis: a multistep and multifactorial process [First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention]. Cancer Res 1999;52:6735–40. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process [First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention]. Cancer Res 1999;52:6735–40.
4.
go back to reference Guilford PJ, Hopkins JB, Grady WM, Markowitz SD, Willis J, Lynch H, et al. E-cadherin germline mutations define an inherited cancer syndrome dominated by diffuse gastric cancer. Hum Mutat 1999;14:249–55.PubMedCrossRef Guilford PJ, Hopkins JB, Grady WM, Markowitz SD, Willis J, Lynch H, et al. E-cadherin germline mutations define an inherited cancer syndrome dominated by diffuse gastric cancer. Hum Mutat 1999;14:249–55.PubMedCrossRef
5.
go back to reference Sant M, Allemani C, Santaquilani M, Knijn A, Marchesi F, Capocaccia R; EUROCARE Working Group. EUROCARE-4: Survival of cancer patients diagnosed in 1995–1999, results and commentary. Eur J Cancer 2009;45:931–91.PubMedCrossRef Sant M, Allemani C, Santaquilani M, Knijn A, Marchesi F, Capocaccia R; EUROCARE Working Group. EUROCARE-4: Survival of cancer patients diagnosed in 1995–1999, results and commentary. Eur J Cancer 2009;45:931–91.PubMedCrossRef
8.
go back to reference Watanabe K, Ogata S, Kawazoe S, Watanabe K, Koyama T, Kajiwara T, et al. Clinical outcomes of EMR for gastric tumors: historical pilot evaluation between endoscopic submucosal dissection and conventional mucosal resection. Gastrointest Endosc 2006;63:776–82.PubMedCrossRef Watanabe K, Ogata S, Kawazoe S, Watanabe K, Koyama T, Kajiwara T, et al. Clinical outcomes of EMR for gastric tumors: historical pilot evaluation between endoscopic submucosal dissection and conventional mucosal resection. Gastrointest Endosc 2006;63:776–82.PubMedCrossRef
9.
go back to reference Gotoda T. Endoscopic resection of early gastric cancer. The Japanese perspective. Curr Opin Gastroenterol 2006;22:561–9.PubMedCrossRef Gotoda T. Endoscopic resection of early gastric cancer. The Japanese perspective. Curr Opin Gastroenterol 2006;22:561–9.PubMedCrossRef
10.
go back to reference Fukase K, Kato M, Kikuchi S, Inoue K, Uemura N, Okamoto S, et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: An open-label randomised trial. Lancet 2008;372:392–7.PubMedCrossRef Fukase K, Kato M, Kikuchi S, Inoue K, Uemura N, Okamoto S, et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: An open-label randomised trial. Lancet 2008;372:392–7.PubMedCrossRef
11.
go back to reference Bozzetti F, Marubini E, Bonfanti G, Miceli R, Piano C, Gennari L. Subtotal versus total gastrectomy for gastric cancer. five-year survival rates in a multicenter randomized Italian trial. Italian Gastrointestinal Tumor Study Group. Ann Surg 1999;230:170–8.PubMedCentralPubMedCrossRef Bozzetti F, Marubini E, Bonfanti G, Miceli R, Piano C, Gennari L. Subtotal versus total gastrectomy for gastric cancer. five-year survival rates in a multicenter randomized Italian trial. Italian Gastrointestinal Tumor Study Group. Ann Surg 1999;230:170–8.PubMedCentralPubMedCrossRef
12.
go back to reference Hartgrink HH, Van der Velde, Putter H, Bonenkamp JJ, Klein Kranenbarg E, Songun I, et al. Extended lymph node dissection for gastric cancer: Who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol 2004;22:2069–77.PubMedCrossRef Hartgrink HH, Van der Velde, Putter H, Bonenkamp JJ, Klein Kranenbarg E, Songun I, et al. Extended lymph node dissection for gastric cancer: Who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol 2004;22:2069–77.PubMedCrossRef
13.
go back to reference McCulloch P, Nita ME, Kazi H, Gama-Rodrigues JJ. Extended versus limited lymph nodes dissection technique for adenocarcinoma of the stomach. Cochrane Database Syst Rev 2004;(4):CD001964. McCulloch P, Nita ME, Kazi H, Gama-Rodrigues JJ. Extended versus limited lymph nodes dissection technique for adenocarcinoma of the stomach. Cochrane Database Syst Rev 2004;(4):CD001964.
14.
go back to reference Marubini E, Bozzetti F, Miceli R, Bonfanti G, Gennari L; Gastrointestinal Tumor Study Group. Lymphadenectomy in gastric cancer: Prognostic role and therapeutic implications. Eur J Surg Oncol 2002;28:406–12.PubMedCrossRef Marubini E, Bozzetti F, Miceli R, Bonfanti G, Gennari L; Gastrointestinal Tumor Study Group. Lymphadenectomy in gastric cancer: Prognostic role and therapeutic implications. Eur J Surg Oncol 2002;28:406–12.PubMedCrossRef
15.
go back to reference Hannan EL, Radzyner M, Rubin D, Dougherty J, Brennan MF. The influence of hospital and surgeon volume on in-hospital mortality for colectomy, gastrectomy, and lung lobectomy in patients with cancer. Surgery 2002;131:6–15.PubMedCrossRef Hannan EL, Radzyner M, Rubin D, Dougherty J, Brennan MF. The influence of hospital and surgeon volume on in-hospital mortality for colectomy, gastrectomy, and lung lobectomy in patients with cancer. Surgery 2002;131:6–15.PubMedCrossRef
16.
go back to reference Birkmeyer JD, Siewers AE, Finlayson EV, Stukel TA, Lucas FL, Batista I, et al. Hospital volume and surgical mortality in the United States. N Engl J Med 2002;346:1128–37.PubMedCrossRef Birkmeyer JD, Siewers AE, Finlayson EV, Stukel TA, Lucas FL, Batista I, et al. Hospital volume and surgical mortality in the United States. N Engl J Med 2002;346:1128–37.PubMedCrossRef
17.
go back to reference Landelijke Werkgroep Gastro-intestinale Tumoren. Richtlijn diagnostiek, behandeling en follow-up van het maagcarcinoom: Versie 1.0. Utrecht: Vereniging van Integrale Kankercentra, 2009. www.mdl.nl/richtlijnen2, geraadpleegd juli 2013. Landelijke Werkgroep Gastro-intestinale Tumoren. Richtlijn diagnostiek, behandeling en follow-up van het maagcarcinoom: Versie 1.0. Utrecht: Vereniging van Integrale Kankercentra, 2009. www.​mdl.​nl/​richtlijnen2, geraadpleegd juli 2013.
18.
go back to reference Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, et al. Perioperative chemotherapy versus surgery alone for respectable gastroesophageal cancer. N Engl J Med 2006;355:11–20.PubMedCrossRef Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, et al. Perioperative chemotherapy versus surgery alone for respectable gastroesophageal cancer. N Engl J Med 2006;355:11–20.PubMedCrossRef
19.
go back to reference Zhao SL, Fang JY. The role of postoperative adjuvant chemotherapy folowing curative resection for gastric cancer: A meta-analysis. Cancer Invest 2008;26:317–25.PubMedCrossRef Zhao SL, Fang JY. The role of postoperative adjuvant chemotherapy folowing curative resection for gastric cancer: A meta-analysis. Cancer Invest 2008;26:317–25.PubMedCrossRef
20.
go back to reference Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, Stemmermann GN, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 2001;345:725–30.PubMedCrossRef Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, Stemmermann GN, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 2001;345:725–30.PubMedCrossRef
21.
go back to reference Hartgrink HH, Putter H, Klein KE, Bonenkamp JJ, Van de Velde CJ. Value of palliative resection in gastric cancer. Br J Surg 2002;89:1438–43.PubMedCrossRef Hartgrink HH, Putter H, Klein KE, Bonenkamp JJ, Van de Velde CJ. Value of palliative resection in gastric cancer. Br J Surg 2002;89:1438–43.PubMedCrossRef
22.
go back to reference Jeurnink SM, Steyerberg EW, Van Hooft JE, Van Eijck CH, Schwartz MP, Vleggaar FP, et al. Surgical gastrojejunostomy or endoscopic stent placement for the palliation of malignant gastric outlet obstruction (SUSTENT study): A multicenter randomized trial. Gastrointest Endosc 2010;71:490–9.PubMedCrossRef Jeurnink SM, Steyerberg EW, Van Hooft JE, Van Eijck CH, Schwartz MP, Vleggaar FP, et al. Surgical gastrojejunostomy or endoscopic stent placement for the palliation of malignant gastric outlet obstruction (SUSTENT study): A multicenter randomized trial. Gastrointest Endosc 2010;71:490–9.PubMedCrossRef
23.
go back to reference Janunger KG, Hafstrom L, Glimelius B. Chemotherapy in gastric cancer: A review and updated meta-analysis. Eur J Surg 2002;168:597–608.PubMedCrossRef Janunger KG, Hafstrom L, Glimelius B. Chemotherapy in gastric cancer: A review and updated meta-analysis. Eur J Surg 2002;168:597–608.PubMedCrossRef
24.
go back to reference Wagner AD, Grothe W, Haerting J, Kleber G, Grothey A, Fleig WE. Chemotherapy in advanced gastric cancer: A systematic review and meta-analysis based on aggregate data. J Clin Oncol 2006;24:2903–9.PubMedCrossRef Wagner AD, Grothe W, Haerting J, Kleber G, Grothey A, Fleig WE. Chemotherapy in advanced gastric cancer: A systematic review and meta-analysis based on aggregate data. J Clin Oncol 2006;24:2903–9.PubMedCrossRef
Metagegevens
Titel
Maagcarcinoom
Auteur
Peter Siersema
Copyright
2014
Uitgeverij
Bohn Stafleu van Loghum
DOI
https://doi.org/10.1007/978-90-368-0436-3_23